{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:02:30Z","timestamp":1773658950433,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.nucmedbio.2012.06.001","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T21:54:03Z","timestamp":1342648443000},"page":"1142-1151","source":"Crossref","is-referenced-by-count":27,"title":["Amplification of DNA damage by a \u03b3H2AX-targeted radiopharmaceutical"],"prefix":"10.1016","volume":"39","author":[{"given":"Bart","family":"Cornelissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Darbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerle","family":"Kersemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Barbeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Smart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine A.","family":"Vallis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrc3007","article-title":"Strategies to improve radiotherapy with targeted drugs","volume":"11","author":"Begg","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0010","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1200\/JCO.2007.11.6202","article-title":"Inhibition of histone deacetylation: a strategy for tumor radiosensitization","volume":"25","author":"Camphausen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0015","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0020","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1200\/JCO.2007.11.5287","article-title":"Antimetabolite radiosensitizers","volume":"25","author":"Shewach","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc2342","article-title":"DNA repair pathways as targets for cancer therapy","volume":"8","author":"Helleday","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2012.06.001_bb0030","first-page":"4S","article-title":"Radiobiologic principles in radionuclide therapy","volume":"46","author":"Kassis","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0035","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4161\/cc.9.2.10475","article-title":"The complexity of phosphorylated H2AX foci formation and DNA repair assembly at DNA double-strand breaks","volume":"9","author":"Nakamura","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0045","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0076-6879(05)09014-2","article-title":"Techniques for gamma-H2AX detection","volume":"409","author":"Nakamura","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0050","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4161\/cc.5.24.3569","article-title":"GammaH2AX in cancer cells: a potential biomarker for cancer diagnostics, prediction and recurrence","volume":"5","author":"Sedelnikova","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/156800906776842957","article-title":"gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy","volume":"6","author":"Kao","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0060","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1158\/0008-5472.CAN-10-4587","article-title":"Imaging DNA damage in vivo using \u03b3H2AX-targeted immunoconjugates","volume":"71","author":"Cornelissen","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cbr.2007.0430","article-title":"Peptide motifs for insertion of radiolabeled biomolecules into cells and routing to the nucleus for cancer imaging or radiotherapeutic applications","volume":"23","author":"Costantini","year":"2008","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2174\/157016310793360657","article-title":"Targeting the nucleus: an overview of Auger-electron radionuclide therapy","volume":"7","author":"Cornelissen","year":"2010","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0075","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/09553000400017663","article-title":"The amazing world of auger electrons","volume":"80","author":"Kassis","year":"2004","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1158\/1078-0432.CCR-05-1109","article-title":"Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts","volume":"12","author":"du Manoir","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.2517-6161.1977.tb01615.x","article-title":"Modelling spatial patterns","volume":"39","author":"Ripley","year":"1977","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.2517-6161.1977.tb01615.x","article-title":"Modelling spatial patterns","volume":"39","author":"Ripley","year":"1977","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0095","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/carcin\/14.9.1733","article-title":"Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA","volume":"14","author":"Collins","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0100","unstructured":"Vojnovic B, Barber PR, Johnston P, Gregory HC, Marples B, Joiner, MC, et al. A high sensitivity, high throughput, automated single-cell gel electrophoresis (\u2018Comet\u2019) DNA damage assay Available online at: http:\/\/users.ox.ac.uk\/~atdgroup\/technicalnotes\/Comet%20analysis.pdf."},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0105","series-title":"PENELOPE-2008: A Code System for Monte Carlo Simulation of Electron and Photon Transport","first-page":"336","author":"Salvat","year":"2008"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0110","series-title":"MIRD: radionuclide data and decay schemes","author":"Eckerman","year":"2008"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0115","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/09553000802395527","article-title":"Auger processes in the 21st century","volume":"84","author":"Howell","year":"2008","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0125","series-title":"Radiation damage in biomolecular systems","first-page":"246","article-title":"Auger emitting radiopharmaceuticals for cancer therapy","author":"Falzone","year":"2012"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nucmedbio.2007.09.007","article-title":"Properties of [(111)In]-labeled HIV-1 tat peptide radioimmunoconjugates in tumor-bearing mice following intravenous or intratumoral injection","volume":"35","author":"Cornelissen","year":"2008","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0135","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2967\/jnumed.107.047399","article-title":"Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences","volume":"49","author":"Kersemans","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0140","first-page":"827","article-title":"Nuclear localizing sequences promote nuclear translocation and enhance the radiotoxicity of the anti-CD33 monoclonal antibody HuM195 labeled with 111In in human myeloid leukemia cells","volume":"47","author":"Chen","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0145","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Gorgoulis","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0150","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartkova","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0155","doi-asserted-by":"crossref","unstructured":"Oka K, Tanaka T, Enoki T, Yoshimura K, Ohshima M, Kubo, M, et al. DNA damage signaling is activated during cancer progression in human colorectal carcinoma. Cancer Biol Ther 9.","DOI":"10.4161\/cbt.9.3.10751"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0160","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.humpath.2008.03.007","article-title":"Expression of gamma-H2AX in melanocytic lesions","volume":"39","author":"Wasco","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0185","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/emboj.2010.32","article-title":"Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells","volume":"29","author":"Rayne","year":"2010","journal-title":"EMBO J"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0190","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1667\/RR0628.1","article-title":"Molecular analysis of base damage clustering associated with a site-specific radiation-induced DNA double-strand break","volume":"166","author":"Datta","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0170","first-page":"303","article-title":"Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments","volume":"35","author":"Goddu","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0175","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2967\/jnumed.109.063156","article-title":"Cellular dosimetry of 111In using monte carlo N-particle computer code: comparison with analytic methods and correlation with in vitro cytotoxicity","volume":"51","author":"Cai","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2012.06.001_bb0180","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nrc2523","article-title":"GammaH2AX and cancer","volume":"8","author":"Bonner","year":"2008","journal-title":"Nat Rev Cancer"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805112001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T06:20:17Z","timestamp":1714198817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805112001357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0969805112001357"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.06.001","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}